UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Are Results From Intermediate-Risk Prostate Cancer Patients Treated Within Clinical Trials Applicable to Real Life?

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E243-E243

2015

Link zum Volltext

Verfügbarkeit prüfen

N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease

International journal of radiation oncology, biology, physics, 2016-12, Vol.96 (5), p.937-937

2016

Link zum Volltext

Verfügbarkeit prüfen

Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

International journal of radiation oncology, biology, physics, 2016, Vol.94 (1), p.2-2

2016

Link zum Volltext

Verfügbarkeit prüfen

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

International journal of radiation oncology, biology, physics, 2016, Vol.94 (1), p.3-3

2016

Link zum Volltext

Verfügbarkeit prüfen

Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S199-S200

2015

Link zum Volltext

Verfügbarkeit prüfen

Acute and Late Urinary Toxicity After Radiation Therapy in Men With and Without an Intact Prostate Gland: A Secondary Analysis of RTOG 9408 and 9601 Suggesting This Toxicity is Not Due to Bladder Injury

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S14-S14

2012

Link zum Volltext

Verfügbarkeit prüfen

PO-0678 HYPOFRACTIONATION WITH ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER: RESULTS AT 8 YEARS

Radiotherapy and oncology, 2012-05, Vol.103, p.S264-S264

2012

Link zum Volltext

Verfügbarkeit prüfen

1044 poster THE IMPACT OF ANTI-COAGULANTS AND STATINS ON PROSTATE CANCER

Radiotherapy and oncology, 2011, Vol.99, p.S389-S389

2011

Link zum Volltext

Verfügbarkeit prüfen

Symptomatic Posttreatment Edema after Stereotactic Radiotherapy for Intracranial Meningiomas: Patterns and Predictive Factors

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e85-e85

2023

Link zum Volltext

Verfügbarkeit prüfen

536 oral RTOG 9601: SALVAGE RT & ANTI-ANDROGEN THERAPY IN PROSTATE CANCER PATIENTS WITH ELEVATED PSA AFTER SURGERY

Radiotherapy and oncology, 2011, Vol.99, p.S219-S219

2011

Link zum Volltext

Verfügbarkeit prüfen

Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme

Journal of clinical oncology, , Vol.18 (6), p.1254-1259

Link zum Volltext

Verfügbarkeit prüfen

Patient Reported Outcomes in High-Risk Prostate Cancer Patients with or without Testosterone Recovery after Androgen Deprivation Therapy

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.S95-S96

2023

Link zum Volltext

Verfügbarkeit prüfen

139 poster: Brachytherapy in the Province of Quebec: A Pattern of Use Study

Radiotherapy and oncology, 2009-05, Vol.91, p.S50-S51

2009

Link zum Volltext

Verfügbarkeit prüfen

A0601 - Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials

European urology, 2024-03, Vol.85, p.S1513-S1513

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.S4-S5

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors in Radium-223 Treatment—An Early Canadian Single-Center Experience

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.E226-E227

2017

Link zum Volltext

Verfügbarkeit prüfen

Liquid Embolization Material Reduces the Delivered Radiation Dose: Clinical Myth or Reality?

American journal of neuroradiology : AJNR, 2012-02, Vol.33 (2), p.320-322

2012

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediate-risk prostate cancer treated with radiotherapy

International Journal of Obesity, 2011-11, Vol.35 (11), p.1421-1426

2011

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Update of NRG Oncology RTOG 94-08

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.S31-S32

2018

Link zum Volltext

Verfügbarkeit prüfen

Elevated MGMT Gene Expression is Independently Associated with Worse Overall Survival in NRG Oncology/RTOG 9813: A Phase III Study of Radiation Therapy (RT) and Temozolomide (TMZ) Versus RT and Nitrosourea (NU) in Anaplastic Grade III Glioma

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.S46-S47

2018

Link zum Volltext

Verfügbarkeit prüfen

Optimizing Whole Brain Radiotherapy Dose and Fractionation: Results from a Prospective Phase III Trial (NCCTG N107C (Alliance)/CEC.3)

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.S10-S10

2019

Link zum Volltext

Verfügbarkeit prüfen

Procarbazine, lomustine and vincristine toxicity in low-grade gliomas

Current oncology (Toronto), 2018-02, Vol.25 (1), p.e33-39

2018

Link zum Volltext

Verfügbarkeit prüfen

MGMT Promoter Methylation Status Independently Predicts Overall Survival in Anaplastic Astrocytoma in NRG Oncology/RTOG 9813: A Phase 3 Trial of Radiation Plus Nitrosourea Versus Radiation Plus Temozolomide

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.S99-S100

2017

Link zum Volltext

Verfügbarkeit prüfen

Significance of Testosterone Suppression in Localized Prostate Cancer Treated with Androgen Deprivation Therapy and Radiotherapy: Data from 2 Phase 3 Trials

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.S131-S132

2017

Link zum Volltext

Verfügbarkeit prüfen

RTOG 0424: Preliminary results of a phase II study of a temozolomide (TMZ) and radiotherapy (RT) in high risk low grade gliomas (LGGs)

Canadian journal of neurological sciences, 2014-10, Vol.41 (s2), p.S7-S7

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(40)

Sprache

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(10)
Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Radiology
(6)
Clinical Neurology
(5)
Humans
(5)
Middle Aged
(5)
Neurosciences & Neurology
(5)
Aged
(4)
Female
(4)
Male
(4)
Oncology
(4)
Adult
(3)
Combined Modality Therapy
(3)
Prognosis
(3)
Brain Neoplasms - Therapy
(2)
Glioblastoma - Radiotherapy
(2)
Original
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Are Results From Intermediate-Risk Prostate Cancer Patients Treated Within Clinical Trials Applicable to Real Life?

N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease

Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer

Acute and Late Urinary Toxicity After Radiation Therapy in Men With and Without an Intact Prostate Gland: A Secondary Analysis of RTOG 9408 and 9601 Suggesting This Toxicity is Not Due to Bladder Injury

PO-0678 HYPOFRACTIONATION WITH ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER: RESULTS AT 8 YEARS

1044 poster THE IMPACT OF ANTI-COAGULANTS AND STATINS ON PROSTATE CANCER

Symptomatic Posttreatment Edema after Stereotactic Radiotherapy for Intracranial Meningiomas: Patterns and Predictive Factors

536 oral RTOG 9601: SALVAGE RT & ANTI-ANDROGEN THERAPY IN PROSTATE CANCER PATIENTS WITH ELEVATED PSA AFTER SURGERY

Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme

Patient Reported Outcomes in High-Risk Prostate Cancer Patients with or without Testosterone Recovery after Androgen Deprivation Therapy

139 poster: Brachytherapy in the Province of Quebec: A Pattern of Use Study

A0601 - Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials

Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer

Prognostic Factors in Radium-223 Treatment—An Early Canadian Single-Center Experience

Liquid Embolization Material Reduces the Delivered Radiation Dose: Clinical Myth or Reality?

Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediate-risk prostate cancer treated with radiotherapy

Long-Term Update of NRG Oncology RTOG 94-08

Elevated MGMT Gene Expression is Independently Associated with Worse Overall Survival in NRG Oncology/RTOG 9813: A Phase III Study of Radiation Therapy (RT) and Temozolomide (TMZ) Versus RT and Nitrosourea (NU) in Anaplastic Grade III Glioma

Optimizing Whole Brain Radiotherapy Dose and Fractionation: Results from a Prospective Phase III Trial (NCCTG N107C (Alliance)/CEC.3)

Procarbazine, lomustine and vincristine toxicity in low-grade gliomas

MGMT Promoter Methylation Status Independently Predicts Overall Survival in Anaplastic Astrocytoma in NRG Oncology/RTOG 9813: A Phase 3 Trial of Radiation Plus Nitrosourea Versus Radiation Plus Temozolomide

Significance of Testosterone Suppression in Localized Prostate Cancer Treated with Androgen Deprivation Therapy and Radiotherapy: Data from 2 Phase 3 Trials

RTOG 0424: Preliminary results of a phase II study of a temozolomide (TMZ) and radiotherapy (RT) in high risk low grade gliomas (LGGs)

Suchergebnisse filtern